» Articles » PMID: 32611640

Prevalence of MRI Abnormalities in People with Epilepsy in Rural China

Overview
Journal Neurology
Specialty Neurology
Date 2020 Jul 3
PMID 32611640
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the prevalence of brain MRI abnormalities in people with epilepsy in rural China and to compare it with that of individuals in the United Kingdom.

Methods: Brain MRI scans were obtained in people with epilepsy who participated in a rural community-based program in China between July 2010 and December 2012. Individual epileptogenic lesion types were reviewed and their associations with seizure control examined. The MRI findings were compared with 2 previous similar studies in the United Kingdom.

Results: Among the 597 individuals (58% male, median age 38 years) with MRI scans analyzed, 488 (82%) had active epilepsy. The MRI was abnormal in 389 individuals (65%), with potentially epileptogenic lesion in 224 (38%) and nonspecific abnormalities in 165 (28%), and 108 (18%) were potentially resectable. The potentially epileptogenic lesions were less frequently detected in children (<18 years old, 12 of 68, 18%) than in adults (212 of 529, 40%; < 0.001). In people with potentially epileptogenic lesions, 67% (150 of 224) had failed ≥2 antiseizure medications. They had higher risk of uncontrolled epilepsy than those with normal MRI (risk ratio [RR] 1.25; < 0.001) and those with nonspecific abnormality (RR 1.15; = 0.002) after adjustment for age and sex. The diagnostic yield of MRI was similar to that reported in community- and hospital-based studies in the United Kingdom.

Conclusions: More than one-third of people with chronic epilepsy in rural China have potentially epileptogenic lesions identifiable on brain MRI, with two-thirds fulfilling the definition of pharmacoresistance. These findings highlight the magnitude of the unmet needs for epilepsy surgery in China.

Citing Articles

Big data research is everyone's research-Making epilepsy data science accessible to the global community: Report of the ILAE big data commission.

Josephson C, Aronica E, Beniczky S, Boyce D, Cavalleri G, Denaxas S Epileptic Disord. 2024; 26(6):733-752.

PMID: 39446076 PMC: 11651381. DOI: 10.1002/epd2.20288.

References
1.
Winston G, Micallef C, Kendell B, Bartlett P, Williams E, Burdett J . The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res. 2013; 105(3):349-55. PMC: 3888924. DOI: 10.1016/j.eplepsyres.2013.02.022. View

2.
Ottman R, Barker-Cummings C, Leibson C, Vasoli V, Hauser W, Buchhalter J . Validation of a brief screening instrument for the ascertainment of epilepsy. Epilepsia. 2009; 51(2):191-7. PMC: 2844922. DOI: 10.1111/j.1528-1167.2009.02274.x. View

3.
West S, Nevitt S, Cotton J, Gandhi S, Weston J, Sudan A . Surgery for epilepsy. Cochrane Database Syst Rev. 2019; 6:CD010541. PMC: 6591702. DOI: 10.1002/14651858.CD010541.pub3. View

4.
Placencia M, Suarez J, Crespo F, Sander J, Shorvon S, ELLISON R . A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology. 1992; 11(2):74-84. DOI: 10.1159/000110915. View

5.
Wang W, Wu J, Wang D, Dai X, Yang B, Wang T . The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology. 2003; 60(9):1544-5. DOI: 10.1212/01.wnl.0000059867.35547.de. View